Clinical Trials Browser

Phase 1/2 × 1-methyltryptophan × Dermatologic × Clear all

NCT02073123 2020-06-05

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

Phase 1/2 Completed

Melanoma